6,766 research outputs found
Assessing batch effects of genotype calling algorithm BRLMM for the Affymetrix GeneChip Human Mapping 500 K array set using 270 HapMap samples
<p>Abstract</p> <p>Background</p> <p>Genome-wide association studies (GWAS) aim to identify genetic variants (usually single nucleotide polymorphisms [SNPs]) across the entire human genome that are associated with phenotypic traits such as disease status and drug response. Highly accurate and reproducible genotype calling are paramount since errors introduced by calling algorithms can lead to inflation of false associations between genotype and phenotype. Most genotype calling algorithms currently used for GWAS are based on multiple arrays. Because hundreds of gigabytes (GB) of raw data are generated from a GWAS, the samples are typically partitioned into batches containing subsets of the entire dataset for genotype calling. High call rates and accuracies have been achieved. However, the effects of batch size (i.e., number of chips analyzed together) and of batch composition (i.e., the choice of chips in a batch) on call rate and accuracy as well as the propagation of the effects into significantly associated SNPs identified have not been investigated. In this paper, we analyzed both the batch size and batch composition for effects on the genotype calling algorithm BRLMM using raw data of 270 HapMap samples analyzed with the Affymetrix Human Mapping 500 K array set.</p> <p>Results</p> <p>Using data from 270 HapMap samples interrogated with the Affymetrix Human Mapping 500 K array set, three different batch sizes and three different batch compositions were used for genotyping using the BRLMM algorithm. Comparative analysis of the calling results and the corresponding lists of significant SNPs identified through association analysis revealed that both batch size and composition affected genotype calling results and significantly associated SNPs. Batch size and batch composition effects were more severe on samples and SNPs with lower call rates than ones with higher call rates, and on heterozygous genotype calls compared to homozygous genotype calls.</p> <p>Conclusion</p> <p>Batch size and composition affect the genotype calling results in GWAS using BRLMM. The larger the differences in batch sizes, the larger the effect. The more homogenous the samples in the batches, the more consistent the genotype calls. The inconsistency propagates to the lists of significantly associated SNPs identified in downstream association analysis. Thus, uniform and large batch sizes should be used to make genotype calls for GWAS. In addition, samples of high homogeneity should be placed into the same batch.</p
Automated SNP genotype clustering algorithm to improve data completeness in high-throughput SNP genotyping datasets from custom arrays
High-throughput SNP genotyping platforms use automated genotype calling algorithms to assign genotypes. While these algorithms work efficiently for individual platforms, they are not compatible with other platforms, and have individual biases that result in missed genotype calls. Here we present data on the use of a second complementary SNP genotype clustering algorithm. The algorithm was originally designed for individual fluorescent SNP genotyping assays, and has been optimized to permit the clustering of large datasets generated from custom-designed Affymetrix SNP panels. In an analysis of data from a 3K array genotyped on 1,560 samples, the additional analysis increased the overall number of genotypes by over 45,000, significantly improving the completeness of the experimental data. This analysis suggests that the use of multiple genotype calling algorithms may be advisable in high-throughput SNP genotyping experiments. The software is written in Perl and is available from the corresponding author
Using GWAS Data to Identify Copy Number Variants Contributing to Common Complex Diseases
Copy number variants (CNVs) account for more polymorphic base pairs in the
human genome than do single nucleotide polymorphisms (SNPs). CNVs encompass
genes as well as noncoding DNA, making these polymorphisms good candidates for
functional variation. Consequently, most modern genome-wide association studies
test CNVs along with SNPs, after inferring copy number status from the data
generated by high-throughput genotyping platforms. Here we give an overview of
CNV genomics in humans, highlighting patterns that inform methods for
identifying CNVs. We describe how genotyping signals are used to identify CNVs
and provide an overview of existing statistical models and methods used to
infer location and carrier status from such data, especially the most commonly
used methods exploring hybridization intensity. We compare the power of such
methods with the alternative method of using tag SNPs to identify CNV carriers.
As such methods are only powerful when applied to common CNVs, we describe two
alternative approaches that can be informative for identifying rare CNVs
contributing to disease risk. We focus particularly on methods identifying de
novo CNVs and show that such methods can be more powerful than case-control
designs. Finally we present some recommendations for identifying CNVs
contributing to common complex disorders.Comment: Published in at http://dx.doi.org/10.1214/09-STS304 the Statistical
Science (http://www.imstat.org/sts/) by the Institute of Mathematical
Statistics (http://www.imstat.org
Using the R Package crlmm for Genotyping and Copy Number Estimation
Genotyping platforms such as Affymetrix can be used to assess genotype-phenotype as well as copy number-phenotype associations at millions of markers. While genotyping algorithms are largely concordant when assessed on HapMap samples, tools to assess copy number changes are more variable and often discordant. One explanation for the discordance is that copy number estimates are susceptible to systematic differences between groups of samples that were processed at different times or by different labs. Analysis algorithms that do not adjust for batch effects are prone to spurious measures of association. The R package crlmm implements a multilevel model that adjusts for batch effects and provides allele-specific estimates of copy number. This paper illustrates a workflow for the estimation of allele-specific copy number and integration of the marker-level estimates with complimentary Bioconductor software for inferring regions of copy number gain or loss. All analyses are performed in the statistical environment R.
An integrated Bayesian analysis of LOH and copy number data
BACKGROUND Cancer and other disorders are due to genomic lesions. SNP-microarrays are able to measure simultaneously both genotype and copy number (CN) at several Single Nucleotide Polymorphisms (SNPs) along the genome. CN is defined as the number of DNA copies, and the normal is two, since we have two copies of each chromosome. The genotype of a SNP is the status given by the nucleotides (alleles) which are present on the two copies of DNA. It is defined homozygous or heterozygous if the two alleles are the same or if they differ, respectively. Loss of heterozygosity (LOH) is the loss of the heterozygous status due to genomic events. Combining CN and LOH data, it is possible to better identify different types of genomic aberrations. For example, a long sequence of homozygous SNPs might be caused by either the physical loss of one copy or a uniparental disomy event (UPD), i.e. each SNP has two identical nucleotides both derived from only one parent. In this situation, the knowledge of the CN can help in distinguishing between these two events. RESULTS To better identify genomic aberrations, we propose a method (called gBPCR) which infers the type of aberration occurred, taking into account all the possible influence in the microarray detection of the homozygosity status of the SNPs, resulting from an altered CN level. Namely, we model the distributions of the detected genotype, given a specific genomic alteration and we estimate the parameters involved on public reference datasets. The estimation is performed similarly to the modified Bayesian Piecewise Constant Regression, but with improved estimators for the detection of the breakpoints.Using artificial and real data, we evaluate the quality of the estimation of gBPCR and we also show that it outperforms other well-known methods for LOH estimation. CONCLUSIONS We propose a method (gBPCR) for the estimation of both LOH and CN aberrations, improving their estimation by integrating both types of data and accounting for their relationships. Moreover, gBPCR performed very well in comparison with other methods for LOH estimation and the estimated CN lesions on real data have been validated with another technique.This work was supported by Swiss National Science Foundation (grants
205321-112430, 205320-121886/1); Oncosuisse grants OCS-1939-8-2006 and
OCS - 02296-08-2008; Cantone Ticino ("Computational life science/Ticino in
reteā program); Fondazione per la Ricerca e la Cura sui Linfomi (Lugano,
Switzerland)
Towards Better Understanding of Artifacts in Variant Calling from High-Coverage Samples
Motivation: Whole-genome high-coverage sequencing has been widely used for
personal and cancer genomics as well as in various research areas. However, in
the lack of an unbiased whole-genome truth set, the global error rate of
variant calls and the leading causal artifacts still remain unclear even given
the great efforts in the evaluation of variant calling methods.
Results: We made ten SNP and INDEL call sets with two read mappers and five
variant callers, both on a haploid human genome and a diploid genome at a
similar coverage. By investigating false heterozygous calls in the haploid
genome, we identified the erroneous realignment in low-complexity regions and
the incomplete reference genome with respect to the sample as the two major
sources of errors, which press for continued improvements in these two areas.
We estimated that the error rate of raw genotype calls is as high as 1 in
10-15kb, but the error rate of post-filtered calls is reduced to 1 in 100-200kb
without significant compromise on the sensitivity.
Availability: BWA-MEM alignment: http://bit.ly/1g8XqRt; Scripts:
https://github.com/lh3/varcmp; Additional data:
https://figshare.com/articles/Towards_better_understanding_of_artifacts_in_variating_calling_from_high_coverage_samples/981073Comment: Published versio
Conflation of short identity-by-descent segments bias their inferred length distribution
Identity-by-descent (IBD) is a fundamental concept in genetics with many
applications. In a common definition, two haplotypes are said to contain an IBD
segment if they share a segment that is inherited from a recent shared common
ancestor without intervening recombination. Long IBD segments (> 1cM) can be
efficiently detected by a number of algorithms using high-density SNP array
data from a population sample. However, these approaches detect IBD based on
contiguous segments of identity-by-state, and such segments may exist due to
the conflation of smaller, nearby IBD segments. We quantified this effect using
coalescent simulations, finding that nearly 40% of inferred segments 1-2cM long
are results of conflations of two or more shorter segments, under demographic
scenarios typical for modern humans. This biases the inferred IBD segment
length distribution, and so can affect downstream inferences. We observed this
conflation effect universally across different IBD detection programs and human
demographic histories, and found inference of segments longer than 2cM to be
much more reliable (less than 5% conflation rate). As an example of how this
can negatively affect downstream analyses, we present and analyze a novel
estimator of the de novo mutation rate using IBD segments, and demonstrate that
the biased length distribution of the IBD segments due to conflation can lead
to inflated estimates if the conflation is not modeled. Understanding the
conflation effect in detail will make its correction in future methods more
tractable
Reconstructing DNA copy number by joint segmentation of multiple sequences
The variation in DNA copy number carries information on the modalities of
genome evolution and misregulation of DNA replication in cancer cells; its
study can be helpful to localize tumor suppressor genes, distinguish different
populations of cancerous cell, as well identify genomic variations responsible
for disease phenotypes. A number of different high throughput technologies can
be used to identify copy number variable sites, and the literature documents
multiple effective algorithms. We focus here on the specific problem of
detecting regions where variation in copy number is relatively common in the
sample at hand: this encompasses the cases of copy number polymorphisms,
related samples, technical replicates, and cancerous sub-populations from the
same individual. We present an algorithm based on regularization approaches
with significant computational advantages and competitive accuracy. We
illustrate its applicability with simulated and real data sets.Comment: 54 pages, 5 figure
- ā¦